{"id":264,"date":"2019-11-14T21:05:23","date_gmt":"2019-11-15T02:05:23","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-14-xanthine-derivatives\/"},"modified":"2023-08-15T13:09:11","modified_gmt":"2023-08-15T17:09:11","slug":"5-14-xanthine-derivatives","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-14-xanthine-derivatives\/","title":{"raw":"5.14 Xanthine Derivatives","rendered":"5.14 Xanthine Derivatives"},"content":{"raw":"<h1>Xanthine Derivatives<\/h1>\r\nTheophylline is a xanthine derivative.\r\n<h2>Mechanism of Action<\/h2>\r\nTheophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction.\r\n<h2>Indications for Use<\/h2>\r\nTheophylline is used for the long-term management of persistent asthma that is unresponsive to beta agonists or inhaled corticosteroids.\r\n<h2>Adverse\/Side Effects<\/h2>\r\nTheophylline can cause nausea, vomiting, CNS stimulation, nervousness, and insomnia.[footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote]\r\n<h2>Nursing Considerations Across a Life Span<\/h2>\r\nThe long term use of these drugs with childhood asthma needs to be reassessed. Although for alleviating symptoms in children they are considered a first line preventer, evidence questions the reliability of these drugs.\u00a0 Currently, used as prescribed by a medical professional, they are deemed safe, however as research advances these indications may change. Further research is indicated.\r\n<h2>Client Teaching &amp; Education<\/h2>\r\nClients should be sure to take medications as prescribed and at appropriate intervals.\u00a0 They should avoid irritants and drink fluids to help thin secretions.\u00a0 Clients will need to have their serum blood levels tested every six to twelve months.[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n<h1>Theophylline Medication Card<\/h1>\r\nNow let's take a closer look at the medication card on theophylline.[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>.[\/footnote][footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer.[\/footnote],[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a>\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>.[\/footnote] Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h2 class=\"textbox__title\">Medication Card 5.14.1: Theophylline<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Class:<\/strong> Xanthine Derivatives\r\n\r\n<strong>Prototypes: <\/strong>Theophylline\r\n\r\n<strong>Mechanism: <\/strong>Theophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction\r\n<h3>Therapeutic Effects<\/h3>\r\n<ul>\r\n \t<li>Prevents wheezing<\/li>\r\n \t<li>Shortness of breath<\/li>\r\n \t<li>Chest tightness caused by asthma and other lung diseases like chronic bronchitis, emphysema<\/li>\r\n<\/ul>\r\n<h3>Administration<\/h3>\r\n<ul>\r\n \t<li>PO and extended release PO once a day dosage<\/li>\r\n<\/ul>\r\n<h3>Indications<\/h3>\r\n<ul>\r\n \t<li>Theophylline is used for the long-term management of persistent asthma and COPD that is unresponsive to beta agonists or inhaled corticosteroids<\/li>\r\n<\/ul>\r\n<h3>Contraindications<\/h3>\r\n<ul>\r\n \t<li>Active peptic ulcer disease<\/li>\r\n \t<li>Seizure disorders<\/li>\r\n \t<li>Cardiac arrhythmias<\/li>\r\n \t<li>Long acting sustained release should not be used in patients with chronic clearance disorders<\/li>\r\n \t<li>smoking<\/li>\r\n<\/ul>\r\n<h3>Side Effects<\/h3>\r\n<ul>\r\n \t<li>Nausea and Vomiting<\/li>\r\n \t<li>CNS stimulation<\/li>\r\n \t<li>Nervousness<\/li>\r\n \t<li>Insomnia<\/li>\r\n \t<li><strong>Safety: <\/strong>Can be used with diminished kidney and liver activity with specific monitoring to avoid fatal toxicities \u2013prescribing professional to determine risk to benefit ratio. If vomiting occurs- toxicity is a possibility so checking labs and going to ER is important to understand<\/li>\r\n<\/ul>\r\n<h3>Nursing Considerations<\/h3>\r\n<ul>\r\n \t<li>Avoid respiratory irritants<\/li>\r\n \t<li>Drink 2-3 L of water per day to help thin secretions<\/li>\r\n \t<li>Serum blood levels q6-12 months to follow and track labs and prevent toxicity<\/li>\r\n \t<li>Avoid caffeine<\/li>\r\n \t<li>Stop smoking interactions occur<\/li>\r\n \t<li>This drug is not a rescue medication<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/div>","rendered":"<h1>Xanthine Derivatives<\/h1>\n<p>Theophylline is a xanthine derivative.<\/p>\n<h2>Mechanism of Action<\/h2>\n<p>Theophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction.<\/p>\n<h2>Indications for Use<\/h2>\n<p>Theophylline is used for the long-term management of persistent asthma that is unresponsive to beta agonists or inhaled corticosteroids.<\/p>\n<h2>Adverse\/Side Effects<\/h2>\n<p>Theophylline can cause nausea, vomiting, CNS stimulation, nervousness, and insomnia.<a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-264-1\" href=\"#footnote-264-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/p>\n<h2>Nursing Considerations Across a Life Span<\/h2>\n<p>The long term use of these drugs with childhood asthma needs to be reassessed. Although for alleviating symptoms in children they are considered a first line preventer, evidence questions the reliability of these drugs.\u00a0 Currently, used as prescribed by a medical professional, they are deemed safe, however as research advances these indications may change. Further research is indicated.<\/p>\n<h2>Client Teaching &amp; Education<\/h2>\n<p>Clients should be sure to take medications as prescribed and at appropriate intervals.\u00a0 They should avoid irritants and drink fluids to help thin secretions.\u00a0 Clients will need to have their serum blood levels tested every six to twelve months.<a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-264-2\" href=\"#footnote-264-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/p>\n<h1>Theophylline Medication Card<\/h1>\n<p>Now let&#8217;s take a closer look at the medication card on theophylline.<a class=\"footnote\" title=\"This work is a derivative of\u00a0Pharmacology Notes: Nursing Implications for Clinical Practice\u00a0by\u00a0Gloria Velarde\u00a0licensed under\u00a0CC BY-NC-SA 4.0.\" id=\"return-footnote-264-3\" href=\"#footnote-264-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0(11th ed.). Wolters Kluwer.\" id=\"return-footnote-264-4\" href=\"#footnote-264-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a>,<a class=\"footnote\" title=\"This work is a derivative of\u00a0Daily Med\u00a0by\u00a0U.S. National Library of Medicine\u00a0in the public domain.\" id=\"return-footnote-264-5\" href=\"#footnote-264-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a> Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h2 class=\"textbox__title\">Medication Card 5.14.1: Theophylline<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Class:<\/strong> Xanthine Derivatives<\/p>\n<p><strong>Prototypes: <\/strong>Theophylline<\/p>\n<p><strong>Mechanism: <\/strong>Theophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction<\/p>\n<h3>Therapeutic Effects<\/h3>\n<ul>\n<li>Prevents wheezing<\/li>\n<li>Shortness of breath<\/li>\n<li>Chest tightness caused by asthma and other lung diseases like chronic bronchitis, emphysema<\/li>\n<\/ul>\n<h3>Administration<\/h3>\n<ul>\n<li>PO and extended release PO once a day dosage<\/li>\n<\/ul>\n<h3>Indications<\/h3>\n<ul>\n<li>Theophylline is used for the long-term management of persistent asthma and COPD that is unresponsive to beta agonists or inhaled corticosteroids<\/li>\n<\/ul>\n<h3>Contraindications<\/h3>\n<ul>\n<li>Active peptic ulcer disease<\/li>\n<li>Seizure disorders<\/li>\n<li>Cardiac arrhythmias<\/li>\n<li>Long acting sustained release should not be used in patients with chronic clearance disorders<\/li>\n<li>smoking<\/li>\n<\/ul>\n<h3>Side Effects<\/h3>\n<ul>\n<li>Nausea and Vomiting<\/li>\n<li>CNS stimulation<\/li>\n<li>Nervousness<\/li>\n<li>Insomnia<\/li>\n<li><strong>Safety: <\/strong>Can be used with diminished kidney and liver activity with specific monitoring to avoid fatal toxicities \u2013prescribing professional to determine risk to benefit ratio. If vomiting occurs- toxicity is a possibility so checking labs and going to ER is important to understand<\/li>\n<\/ul>\n<h3>Nursing Considerations<\/h3>\n<ul>\n<li>Avoid respiratory irritants<\/li>\n<li>Drink 2-3 L of water per day to help thin secretions<\/li>\n<li>Serum blood levels q6-12 months to follow and track labs and prevent toxicity<\/li>\n<li>Avoid caffeine<\/li>\n<li>Stop smoking interactions occur<\/li>\n<li>This drug is not a rescue medication<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-264-1\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-264-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-264-2\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-264-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-264-3\">This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>. <a href=\"#return-footnote-264-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-264-4\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-264-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-264-5\">This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a>\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>. <a href=\"#return-footnote-264-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":90,"menu_order":14,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-264","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":209,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":5,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/264\/revisions"}],"predecessor-version":[{"id":1738,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/264\/revisions\/1738"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/209"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/264\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=264"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=264"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=264"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}